An Educational Opportunity for Clinicians Specializing in the diagnosis of
Clostridium difficile Infections



Stuart H. Cohen, MD, FACP, FIDSA (Chair)
Professor of Medicine
Division of Infectious Diseases
Director of Hospital Epidemiology and Infection Control
University of California, Davis Medical Center
Sacramento, CA

Dale N. Gerding, MD  (Faculty)
Professor of Medicine
Division of Infectious Diseases
Loyola University Chicago Stritch School of Medicine
Research and Medicine, Edward Hines Jr. Veterans Affairs Hospital
Chicago, IL

Ciáran P. Kelly, MD (Faculty)
Professor of Medicine Harvard Medical School
Director, Gastroenterology Fellowship Training
Director, Celiac Center
Beth Israel Deaconess Medical Center
Boston, MA


The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity. ACHL also requires participating faculty to disclose when unapproved/unlabeled uses of a product are discussed in a CME/CE activity.

This CME activity might describe the off-label, investigational, or experimental use of medications and/or devices  that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

The following disclosure information has been provided:


Stuart H. Cohen, MD, FACP, FIDSA  (Chair)
Consultant: Cubist Pharmaceuticals, Merck and Pfizer
Research Support: Cubist Pharmaceuticals and ViroPharma


Dale N. Gerding, MD(Faculty)
Advisory Board: Actelion, Merck and Rebiotix
Consultant: Sanofi-Pasteur and ViroPharma
Steering Committee: Sanofi-Pasteur

Ciarán P. Kelly, MD (Faculty)
Advisory Board: Cubist Pharmaceuticals

Discussion of Off-Label, Investigational, or Experimental Drug Use: The faculty may discuss the use of metronidazole for the treatment of C. diff infections

Staff and Reviewer

ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.